Sleep and Health Education Program at Harvard

New Treatment for Obstructive Sleep Apnea?
--Weight loss drug decreases OSA severity in clinical trials.

Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesity | Eli Lilly and Company The Investor Relations website contains information about Eli Lilly and Company's business for stockholders, potential investors, and financial analysts.

A study evaluating commercially available sleep trackers is now recruiting!

Click here for more info: https://rally.massgeneralbrigham.org/study/sleeptrackerstudy